Liver disease is on the rise in the United States. Women are at a higher risk of developing a certain type of liver disease called Primary Biliary Cholangitis, ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

NORTHAMPTON, MA / ACCESS Newswire / May 15, 2025 / "Living with primary biliary cholangitis (PBC) can be an isolating ...

GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC). Interim results from the ...

Zurich (Switzerland), May 20, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients ...

MAIT cells are good fighters. Researchers have found that MAIT cells can respond very quickly to infections. Their speed ...

A low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, polyols) diet can improve patients' irritable ...

We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a ...

Zydus Lifesciences is targeting double-digit revenue growth for the fiscal year 2026, driven by robust performance in its ...

Mirum Pharmaceuticals, Inc. today announced the appointment of Doug Sheehy, JD, as chief legal officer. Mr. Sheehy was most recently chief legal officer and secretary at Sonoma Biotherapeutics, Inc., ...

Antitotal IgG as secondary antibody. ¶ Anti-IgG1, IgG2 and IgG3 as secondary antibody. # 17 additional healthy controls tested negative. IIF: Immunofluorescence; PBC: Primary biliary cirrhosis.